Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNA vaccine against SARS-CoV-2 variants

RNA vaccine against SARS-CoV-2 variants

US Patent 11918643 · Granted Mar 5, 2024

Estimated economic value: $5,547,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Influenza mRNA vaccines2025
Coronavirus vaccine2025
Coronavirus vaccine2025
RSV RNA molecules and compositions for vaccination2025
Rotavirus vaccines2025
Coronavirus vaccine2025
Coronavirus vaccine2025
Nucleic acid base vaccine against emerging SARS-CoV-2 variants2025
Nucleic acid base vaccine against emerging SARS-CoV-2 variants2025
Compositions comprising a norovirus nucleic acid and methods of use thereof2024
Methods for generating, evaluating, gene editing and cloning pluripotent stem ce2024
RSV RNA molecules and compositions for vaccination2024